Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Strongbridge Biopharma plc Announces Underwriters’ Partial Exercise of Option to Purchase Additional Shares
-
Strongbridge Biopharma (SBBP) Prices 5M Offering of Ordinary Shares at $6.75/Share
-
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
-
Strongbridge Biopharma (SBBP) Plans Offering of 5M Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
-
Strongbridge Biopharma (SBBP) Buys U.S. and Canadian Rights to MACRILEN from Aeterna Zentaris (AEZS)
-
Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
-
Cantor Fitzgerald Starts Strongbridge Biopharma (SBBP) at Overweight Noting Undervalued Shares
-
Strongbridge Biopharma plc Announces Closing of Public Offering of Ordinary Shares
-
Strongbridge Biopharma (SBBP) Prices 4M Offering of Ordinary Shares $6.25/Share
-
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
-
Strongbridge Biopharma (SBBP) Plans Offering of Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
-
Strongbridge Biopharma plc to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Strongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
